AstraZeneca announced the appointment of Iskra Reic as Executive Vice President (EVP), International, effective immediately. Reic will oversee the company’s strategy and growth across the vast International region, including markets in China, Asia, Eurasia, the Middle East & Africa, Latin…
GSK plc and Medicines for Malaria Venture (MMV) have announced a major milestone in the fight against malaria, as the World Health Organization (WHO) has awarded prequalification to tafenoquine. This is the first single-dose medicine for the prevention of relapse…
The World Health Organization (WHO) has granted prequalification to the Xpert® MTB/RIF Ultra molecular diagnostic test, making it the first tuberculosis (TB) diagnostic and antibiotic susceptibility test to meet WHO’s stringent prequalification standards. This marks a pivotal step toward enhancing…
Ipsen and Biomunex Pharmaceuticals have entered into an exclusive global licensing agreement for BMX-502, a promising bispecific antibody designed to target and activate Mucosal-Associated Invariant T cells (MAIT cells) to combat cancer. BMX-502 is specifically engineered to target the GPC3…
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company dedicated to central nervous system (CNS) therapeutics, has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA). The application seeks approval for CAPLYTA…
Orion ensures a steady supply of medicines by manufacturing them in its own facilities, while its subsidiary Fermion produces the active pharmaceutical ingredients (APIs) for these medicines. This integrated production in Finland strengthens the availability of essential medicines not only…
Stallergenes Greer, a leading biopharmaceutical company specializing in allergen immunotherapy (AIT), announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the extension of the indication…
UCB, a global biopharmaceutical leader, has announced the successful completion of its sale, divestment, and licensing agreement for its mature neurology and allergy portfolio in China. The transaction, valued at $680 million, transfers ownership of key products, including Keppra®, Vimpat®,…
BeiGene has announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with chemotherapy as a first-line treatment for two aggressive cancer types: esophageal squamous cell carcinoma (ESCC) and gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This decision is based…
Dr. Reddy’s Laboratories Ltd has announced the launch of Toripalimab in India, marking a significant advancement in the treatment of nasopharyngeal carcinoma (NPC). Toripalimab, a New Biological Entity (NBE), is the first and only immuno-oncology drug approved by regulatory agencies…
Population Health Research Institute (PHRI), a joint initiative of McMaster University and Hamilton Health Sciences, is celebrating its 25th anniversary as a global leader in health research. Over the past quarter-century, PHRI has made transformative contributions to patient care worldwide…
Pfizer Inc. (NYSE: PFE) has announced the appointment of Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development, effective January 1, 2025. Dr. Boshoff, who most recently served as Pfizer’s Chief Oncology Officer…